Misuse of over the counter medicines in community pharmacies in Scotland by Hill, Duncan et al.
Hill, Duncan and McCabe, Amanda and Paterson, Kelly and Stuart, Jayne 
and Campbell, Derna (2017) Misuse of over the counter medicines in 
community pharmacies in Scotland. Journal of Substance Use. ISSN 
1465-9891 , http://dx.doi.org/10.1080/14659891.2017.1316783
This version is available at https://strathprints.strath.ac.uk/61347/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (https://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any correspondence concerning this service should be sent to the Strathprints administrator: 
strathprints@strath.ac.uk
The Strathprints institutional repository (https://strathprints.strath.ac.uk) is a digital archive of University of Strathclyde research 
outputs. It has been developed to disseminate open access research outputs, expose data about those outputs, and enable the 
management and persistent access to Strathclyde's intellectual output.
Misuse of Over the Counter (OTC) Medicines in Community Pharmacies in Scotland 
Abstract 
The general public are taking more responsibility for their health, using community pharmacy as a 
source to access medication. 
There is a reported increase and change in the misuse of OTC medication from community 
pharmacies in Scotland (Wright et al, 2015).  
This article was designed to examine the self-reported use of medication from a small sample of 
community pharmacies in Scotland. The questionnaire gathered patient demographics and details of 
medicines used.  
The study concentrated on 2 treatment areas, opioid analgesics and sedative antihistamines licensed 
as a sleep aid. Both previously identified as the most prevalent OTC medications that were perceived 
to being misused (Matheson et al, 2007) 
Data was collected over a short time period in 2015 from 15 community pharmacies. The data 
demonstrates the widespread misuse of OTC. The most prevalent group identified as females, 41-60 
years old and employed. It was most commonly reported that the recommended treatment duration 
is exceeded rather than the maximum recommended daily dose. 
The recommendations from the article are that there needs to be greater awareness for 
pharmacists, pharmacy staff and general public on the potential dangers of misusing OTC 
medications and the importance of adhering to the recommended dosing and duration guidelines. 
 
  
Background 
Globally the general public are taking an increasingly greater responsibility for their health; as a 
result the use of OTC medicines for self-medication is growing (Sherazi et al, 2012). A significant 
problem with assessing the scale of OTC medicine use and its misuse is the limited research into the 
problem. Foley et al (2015) looked at the availability of over the counter codeine compounds across 
Europe, but this failed to quantify the scale of the problem, but gave an insight into the number of 
preparations available for the public to buy. It has been a recognised issue over the last few decades, 
however, the research focus remains on illegal drug abuse (Wazaify et al, 2004). 
dŚĞƌĞĂƌĞƚǁŽĐůĂƐƐĞƐŽĨKdŵĞĚŝĐŝŶĞƐŝŶƚŚĞh< P ?'^> ?ŵĞĚŝĐŝŶĞƐǁŚŝĐŚĐĂŶďĞƐŽůĚƚŽƚŚĞŐĞŶĞƌĂů
public from non-ƉŚĂƌŵĂĐǇƐƚŽƌĞƐĂŶĚ ?W ?ŵĞĚŝĐŝŶĞƐǁŚŝch can only be purchased from a registered 
pharmacy requiring the supervision of a pharmacist (Reed et al, 2011). As no prescription is needed 
to purchase these products they can be obtained relatively easily. All products discussed in this 
ƉƌŽũĞĐƚĂƌĞ ?W ? medicines due to the potential for them to be abused /misused.  
The ability of individuals to purchase over-the-counter (OTC) medicines promotes self-management 
ǁŚŝůƐƚĂůůŽǁŝŶŐƉŚĂƌŵĂĐŝƐƚ ?ƐŝŶƉƵƚƚŽďĞacknowledged. Pharmacists have a duty to provide advice 
and recommendation of suitable treatments from a perspective of safety of the medication. The 
safety includes assessment of other conditions, advising on the quantity, duration and dosing of the 
treatment. dŚŝƐďŽƚŚƌĞůŝĞǀĞƐ'W ?ƐǁŽƌŬůŽĂĚĂŶĚĂůůŽǁƐ rapport to be formed, benefitting the 
pharmacist-patient relationship. It is well known amongst the healthcare community that OTC 
medicines may be misused, with patients often underestimating the harm potential, and possible 
complacency amongst individualƐǁŚŽǀŝĞǁƚŚĞƐĞƉƌŽĚƵĐƚƐĂƐ “ƐĂĨĞ ?as they can be purchased. 
To clarify the terms used in this report: abuse refers to the deliberate / intended use of a product for 
reasons other than those indicated, e.g. to experience euphoric or sedative effects, whilst misuse 
refers to the medical use of a product with doses or durations of use in excess of those 
recommended, which may be unintended (Sherazi et al 2012 and Reed et al, 2011).  
Both may occur in patients purchasing medication from community pharmacies, however, how this 
issue is addressed by the pharmacy may differ and the issue may be caused through lack of patient 
awareness and education. Wright et al (2015) reported that a number of pharmacies developed 
strategies to reduce possible misuse, many introduced sales policies ranging from pharmacist 
involvement, refusing sales, GP referral, monitoring of sales, keeping products out of vision, 
removing from sale or offering alternatives. 
Reasons for unintentional misuse may include ƉĂƚŝĞŶƚ ?Ɛ reluctance to visit their GP to address the 
problem or GP discontinuation of medication the patient feels is still necessary. Patients may 
experience side effects from the medication they are overusing, such as in chronic daily headaches 
potentiated by co-codamol. (NICE, 2012) This may instigate continued use in order to treat the issue 
causing an extended cycle of misuse.  
In this article it is not possible to differentiate whether the misuse is intentional or unintentional and 
ĂůƚŚŽƵŐŚƚŚĞĞǆĐĞƐƐŝǀĞĐŽŶƐƵŵƉƚŝŽŶŽƌĚƵƌĂƚŝŽŶŽƌƚƌĞĂƚŵĞŶƚƐǁŝůůďĞĂĚĚƌĞƐƐĞĚ ?ƚŚĞƚĞƌŵ “ŵŝƐƵƐĞ ?
will be used throughout as the intent is unascertained. 
The extent of OTC drug misuse in the UK has not been fully quantified and the total number of 
people affected remains unknown. Research however has looked at what pharmacists perceive the 
problem to be, this has generally only been how often it occurs in their community pharmacy 
(Matheson (2002), Wright (2015)). Wright et al (2015) reported that 80.8% of community 
pharmacists suspected OTC misuse. These papers reported shift in the pharmacists views of the 
medications that are being misused, moving away from the sedating antihistamines (decreasing 
from 51.9% (2000) to 26.4% (2104)) and increasing use of codeine based analgesics (Co-codamol  
(Paracetamol and Codeine) increasing from  11.2% (2000) to 48.5% (2014) and Nurofen Plus 
(Ibuprofen and Codeine proprietary branded product) increasing from 17.9% (2000) to 30.4% (2014)) 
A separate postal study conducted in west central Scotland contacted n=110 pharmacies, reported 
that around one third (31%) have encountered frequent misuse , and 58% encounter occasional 
misuse. The same survey estimated the mean number of patients suspected of OTC misuse to be 
5.63 per week per pharmacy (MacFadyen et al 2001).   Community pharmacy has been shown to be 
a straightforward way to access many medicines. Misusers explained sales could be made in various 
pharmacies located in close proximity and pharmacy staff seldom challenged purchases (Cooper, 
2013).  
Fingleton (2014) recently reported that of 972 members of the general public surveyed, 2% were 
currently or previously addicted to OTC medicine. It may be assumed that people may not recognise 
they are misusing a product and the actual number may be much higher. 
A larger cross-sectional study conducted in Scotland (Wright, 2015) had similar results with reports 
from 57% (n=1246) of pharmacists believing there was a problem in their local area. When 
compared to the findings from the previous studies completed in 1995 (Matheson, 1999), 2000 
(Matheson, 2002) and 2006 (Matheson, 2007) respectively, the percentage of pharmacists that 
perceive that there is OTC misuse has increased 68.4%, 69.0% and 70.8% to the newly reported 
figure of 80.8%. Further evidence of the prevalence of the problem was collected by an anonymous 
questionnaire sent to n=180 community pharmacists across one health authority in South Wales, 
with a higher response rate of 89%. A comparable result of 66% of respondents felt similarly about 
the issue. (Pates et al, 2002). These studies show that pharmacists across the UK are concerned 
about the purchase and subsequent inappropriate use of a range of OTC medication. However, the 
ĂǀĂŝůĂďůĞƐƚƵĚŝĞƐŽŶůǇŐŝǀĞƚŚĞƉŚĂƌŵĂĐŝƐƚ ?ƐƉĞƌĐĞƉƚŝŽŶŽĨƚŚĞƐĐĂůĞŽĨŵŝƐƵƐĞ ?they do not attempt 
to directly quantify its extent or the patients view.  
A few articles on case studies relating to the misuse of OTC medications (Van Hout (2015), Marr and 
Hill (2015)) have been published, demonstrating some of the issues associated with the misuse such 
as health concerns (gastric ulcers and bleeds from prolonged /excessive ibuprofen / codeine use), 
relationship strain and suppression of other health needs e.g. mental health. (Hard (2014) and 
Conroy & Hill (2014)).  
This study will produce some demographic information on patients accessing OTC medications and 
will attempt to provide some quantification of the extent of the issue and also whether this is due to 
excessive consumption or prolonged consumption. 
 
Aim 
The study was developed to identify trends and prevalence of OTC misuse from community 
pharmacies in 3 geographical areas of Scotland in terms of patient demographics, misuse of 
medications, sources of recommendation and action taken if the product was unavailable. 
The study was conducted as part of a final year pharmacy student project undertaken by 3 students 
in 3 geographical areas.   
All data collected was anonymous. Local ethics groups for both University of Strathclyde and NHS 
Lanarkshire were contacted and there was agreement that ethical approval was not required for the 
study.  
 
  
Method 
An easy-to-use short self completion form for data collection in regards to codeine containing 
analgesics and sleep aid medication was developed (Appendix A). The anonymous multiple choice 
forms gathered basic demographics in addition to questions regarding product choice and dosing 
regimens. A restricted number of questions ensured the form was easily comprehended and 
completed in a short period of time. The form was tested for suitability on a small number of 
patients attending an additional pharmacy to ensure clarity and suitability of use. These results are 
not included in the data presented. 
The data collection was completed over a period of two week in January / February 2014 was 
undertaken throughout 15 community pharmacies in Lanarkshire and North East Scotland reflecting 
the geographical areas of the students. 
All patients purchasing either codeine containing analgesics or sleep aids (sedative antihistamines) 
available from the community pharmacy without prescription were invited to self complete a form 
relating to the medication. Patients were offered assistance from the pharmacy staff to complete 
the form if required. All pharmacy staff were briefed on the project and the questionnaires by the 
data collectors, who also spent half a day per week in the community pharmacies to support with 
data collection. 
The completed forms were collected from each of the pharmacies and aggregated per site /group (5 
pharmacies) and analysed. 
  
Results 
Pharmacies 
15 pharmacies (10 in NHS Lanarkshire and 5 in North East Scotland) agreed to participate and these 
were divided between the 3 researchers. The data collection sites were selected from an opt-in 
response to a letter issued to all community pharmacy contractors in the NHS Lanarkshire area. 120 
pharmacies in NHS Lanarkshire were approached with 10 sites self nominating (8%).However the 
sample in North East Scotland, 5 pharmacies were approached due to the increased rurality of the 
location.   
General patient demographics 
A total of 474 completed forms were received throughout the collection period from all the sites. 
The breakdown of replies is contained in Table 1.  
As the forms were self completion, it is not possible to reconcile the number of patients that refused 
or were unwilling to complete a questionnaire therefore results may be a conservative estimate.  
The demographics of the responses are show in Table 2.The gender breakdown of the patients 
completing the forms was 58% female, whilst the most common age group was 41  ? 60 (40.72%), 
followed by 25  ? 40 years (33.76%). Economically, 53.16% were employed (n=252) with 6.54% 
reporting to being in education.   
Of the information reported, over ¾ (76.37%) were for patients purchasing opioid containing 
medication. This was dissected further to the medication obtained, i.e. paracetamol/codeine or 
ibuprofen/codeine. 
Misuse of medication  
Using the definitions outlined previously, 187 of the completed forms (39.45%) were indicative of 
misuse of the medication either due to the quantity of medication consumed or the duration of 
consumption. (Table 3) From the data reported,  the prevalence of females purchasing OTC 
medications in these categories and misusing in relation to the definitions used is 55.1% of the forms 
(n=103). The most common age groups reported are 41  ? 60 years (34.76%) and 25  ? 40 years 
(34.22%). In one area (Site A), the most commonly associated age group with misuse was for the 61+ 
years, although this site had the lowest number of forms returned meeting the criteria for misuse. 
As with the overall data the largest reporting group are employed (39.57%) but there was a greater 
variability between the data collection sites. (Site A covered a more rural area which was more 
affluent than the other areas) 
The shaded areas in Table 4 highlight when the maximum recommended daily quantity has been 
reported as being exceeded. Fewer people reported to misusing excessive numbers of individual 
doses on a daily basis in comparison to the duration of treatment. Only 4 patients reported to using 
paracetamol/codeine (2.14% of the misuse group) in excess of the recommended levels but 13 of 
the ibuprofen/codeine and diphenhydramine (both 6.95% of misuse, n=13) reporting to excessive 
consumption.  
In Table 5, the shaded areas highlight when the recommended duration of self treatment was 
exceeded. It can been seen that all the medications included have been reported as being  used for 
an excessive time period and in addition all were also reported by some as being used continuously. 
Specifically for the codeine containing medication, paracetamol/codeine is being used  by  over 60% 
of the group determined as misusing medication for longer than recommended, with 20.86% using 
this medication continuously. This is reduced for ibuprofen/codeine, with 14.5% of the medication 
misuse group reported to the use of this preparation, and nearly 5% taking it continuously. 
Diphenhydramine can be used for longer before it is classified as misuse, but 14% of the patients 
meet the criteria exceeding the maximum recommended duration with 11% reporting to continuous 
use. Promethazine appears to be less misused with only 3% of patients meeting the definition, 
however it equates to 100% using continuously.  
Table 6 contains the data relating to 2 questions who recommended the medication? and what the 
patient would do if they could not get the medication requested. Friends (32%), were reported as 
the main reported source of recommendation although pharmacy recommendation (26%) and 
discontinued prescribed medication (24%) were widely reported. If patients were unable to get the 
medication requested most responded they would take an alternative (37.34%), although 29.32% 
said they would visit another pharmacy to try to obtain the same product and 27.85% would go to 
ƚŚĞ'W ? ? ? ? ? ?йƐĂŝĚƚŚĞǇǁŽƵůĚ “ĚŽǁŝƚŚŽƵƚ ? the medication whilst only very few (3.24%) reported 
they would purchase on the internet. 
Discussion 
Wright et al, (2015) reported that the prevalence of pharmacists who perceive OTC medication 
misuse from their pharmacies has increased to 80% from levels of 70% in previous studies. This 
article states that codeine containing analgesics are now perceived to be more likely misused than 
other medication groups and the misuse of sleep aid medication has reduced. 
This study goes towards providing further detail around the levels of reported misuse of limited 
groups of medication. The results demonstrate, there is a significant level of patients reporting to 
misusing medication either in terms of the quantity consumed daily or the duration of use. The 
reported data shows this prevalence to be nearly 40% of the completed forms (39.45%).  
From the results, all of the recruited pharmacies experienced patients that were misusing 
medications using the defined criteria despite being in varied locations and socio-demographic 
areas.  
The demographics from the responses illustrate that it is not an issue restricted to a small cohort of 
patients but it is open to all age g, socio-economic and gender groups. However, it is still possible to 
identify from this study some of the more common patient characteristics. I.e. most commonly the 
patients were female, aged 41  ? 60 and employed. It should be noted however this was common to 
both the number of forms returned and responses meeting the misuse criteria. 
The results show that misuse reported more commonly is exceeding recommended treatment 
duration rather than consuming of excessive medication daily. This varied between the medications 
included in the study e.g. Misuse of quantity consumed is greater for ibuprofen-codeine than 
paracetamol-codeine, which is converse to the reported duration of treatment with more patients 
reporting to take paracetamol-codeine continuously (20.86%). The excess consumption of either 
paracetamol-codeine or ibuprofen-codeine can be severe and carry a life threatening risks. E.g.  
hepatotoxic nature of excessive paracetamol and the gastro-intestinal and renal side effects  of 
excessive ibuprofen. 
Recommendations 
The study demonstrated that the misuse of OTC medication is widespread and crossed the socio- 
economic spectrum. From the widespread nature of the issue, there should be calls for a wider 
survey and data collection to allow further investigation with clear and achievable outcomes and 
recommendations such as public awareness of the issue and increased awareness of the problem for 
pharmacists and pharmacy staff. 
Additionally, there is an identified need for increased training and support for healthcare 
professionals including; information on how to communicate with patients potentially misusing OTC 
medicines and updated information regarding misused products.  
This potentially demonstrates the need to develop training on methods used to address the issue of 
OTC misuse with patients and consultation skills to develop a more successful interaction and 
improved patient care. The Royal Pharmaceutical Society in Scotland have commenced offering Local 
Practice Forum meetings to raise the issue of training and awareness and this type of activity should 
be encouraged and widened to ensure there is an offering of this to all pharmacists.  
In the future a possible development could be the introduction of a referral system between 
pharmacies and local services allowing signposting for patients seeking help. Additionally, again for 
the future,  the use of  shared care records between pharmacies and GP surgeries for patients would 
allow information to be kept up to date  and early interventions made. 
Limitations 
The study was a convenience sample and was self reported by the patients. It relied on the 
pharmacists/ staff distributing the questionnaire, inherently building in a number of limitations e.g.  
was it inclusive to all patients? Where the responses from participants honest? Did patients misusing 
medicine opt not to complete the questionnaire? Many of these factors may lead to underreporting 
on the issue of OTC medication misuse.  
The numbers of pharmacies involved was small with fewer than 10% for the Lanarkshire pharmacies 
taking part. The pharmacies in Lanarkshire self selected to take part, the group in the North East 
were approached through the previous experience of the student in the area. If this was to be 
repeated it would be preferable to have a larger number of pharmacies participating and a singular 
approach to recruitment used. 
Data collection was a 2 week period in winter 2014. This is a short time frame for data collection and 
the sample maybe affected by the need for medications to treat seasonal illnesses e.g. colds and flu. 
Prejudiced offering of surveys from staff may affect the data collected as staff are possibly more 
willing to approach patients they know better or that are more willing to complete the 
questionnaire. 
The medication examined was limited to codeine containing analgesics and sleep aids, this is 
restrictive and a wider review including all opioid analgesics, other opioid containing medications 
and antihistamines (sedative) would be able to provide a comprehensive review and examination of 
the issue of OTC medication misuse. 
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